Xarelto generic availability 2026?

Short answer: By 2026, generic rivaroxaban (the active ingredient in Xarelto) is expected to be available in many markets, but exact availability depends on patent expirations, settlements/regulatory approvals in each country. Generics have begun to appear in several places already, with more markets likely to follow.

How to check for your location (current status):
- United States: Check the FDA’s Orange Book for rivaroxaban to see if any generics are approved and whether they’re on formulary or priced similarly to the brand.
- European Union/UK: Check your country’s national health authority or the EMA for approval status of generic rivaroxaban and the current market availability.
- Insurance and pharmacies: Your insurer or local pharmacy can confirm whether a generic version is covered and available at your location.
- Patent/exclusivity status: If you’re curious about timing, you can look up patent expiry and exclusivity information for rivaroxaban in your country, but note that settlements and pediatric extensions can affect real-world availability.

If you tell me your country or region, I can tailor the guidance and help you locate the most up-to-date status for generic rivaroxaban in that area. And as always, don’t switch anticoagulants without talking to your doctor or pharmacist.